SOW
GPCR icon

State of Wyoming’s Structure Therapeutics GPCR Stock Holding History

State of Wyoming’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
3,101
+2,668
+616% +$118K 0.02% 1128
2026
Q1 		$20.9K Sell
433
-1,328
-75% -$90.9K ﹤0.01% 1675
2025
Q4 		$122K Buy
1,761
+403
+30% +$16.5K 0.01% 1242
2025
Q3 		$38K Buy
1,358
+28
+2% +$558 ﹤0.01% 1626
2025
Q2 		$27.6K Buy
+1,330
New +$29.2K ﹤0.01% 1674

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State of Wyoming's GPCR Position: Q2 2026 in Review

State of Wyoming increased its Structure Therapeutics (GPCR) stake by 616% in Q2 2026, buying an estimated $118K and bringing the position to 3,101 shares worth $166K. The position accounts for 0.02% of the portfolio, ranked #1128.

State of Wyoming first reported a position in GPCR in Q2 2025 and has held it in 5 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • State of Wyoming held 3,101 shares of Structure Therapeutics worth $166K as of Q2 2026.
  • State of Wyoming bought 2,668 Structure Therapeutics shares in Q2 2026, an estimated $118K.
  • Structure Therapeutics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1128 holding.
  • State of Wyoming first reported a position in Structure Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.